Merck & Company, Inc. News Headlines

MRK 
$57.88
*  
0.46
0.79%
Get MRK Alerts
*Delayed - data as of Mar. 4, 2015  -  Find a broker to begin trading MRK now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
MRK Crosses Above Key Moving Average Level
12/18/2014 10:58:52 AM - BNK Invest


Merck Acquires OncoEthix for Up to $375 Million
12/18/2014 8:36:00 AM - Dow Jones Business News


Health Care Sector Update for 12/18/2014: ICPT, MRK, CPXX
12/18/2014 8:30:49 AM - MT Newswires


Merck Acquires OncoEthix For $110 Mln Plus Milestone Payments - Quick Facts
12/18/2014 7:43:00 AM - RTT News


Call buyers take a dose of Merck
12/18/2014 7:14:25 AM - optionMONSTER


NPS Pharmaceuticals and Shire Up on Takeover Rumors - Analyst Blog
12/18/2014 6:30:00 AM - Investopedia


Merck's 3.2% Yield Is The Only Reason To Own The Stock
12/18/2014 12:53:00 AM - Seeking Alpha


NewLink Genetics: Examining Likelihood Of Success In The Impress Trial
12/17/2014 3:52:00 PM - Seeking Alpha


NewLink Genetics: Examining Likelihood Of Success In The Impress Trial
12/17/2014 12:50:23 PM - SeekingAlpha


NewLink Genetics: Examining Likelihood Of Success In The IMPRESS Trial
12/17/2014 12:50:00 PM - Seeking Alpha


Cubist Pharmaceuticals: An Extraordinary Arbitrage Opportunity
12/17/2014 11:26:00 AM - Seeking Alpha


The 3 Most Exceptional CEOs of 2014
12/16/2014 7:00:02 PM - Motley Fool


Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog
12/16/2014 6:30:00 PM - Zacks.com


Quick Analysis Of Merck's Acquisition Of Cubist
12/16/2014 1:55:00 PM - Trefis


Pfizer Moving Into Gene Therapy Is A Welcome Move
12/16/2014 1:53:11 PM - Trefis


Assessing Gilead's Reality-Perception Gap
12/16/2014 11:52:00 AM - Seeking Alpha


IUSV, JPM, PFE, MRK: ETF Inflow Alert
12/16/2014 10:55:23 AM - BNK Invest


Graham's Stock Selection Criteria Revisited
12/16/2014 8:52:00 AM - Seeking Alpha


2015 Healthcare Sector Predictions
12/16/2014 6:50:00 AM - Seeking Alpha


Roche Submitted NDA for Melanoma Combination Drug - Analyst Blog
12/16/2014 6:30:00 AM - Investopedia


Backtesting The New Nifty Fifty Using Weighted, Equal-Weight, And Random-Assignment Designs
12/15/2014 3:15:00 PM - Seeking Alpha


Dow Movers: MRK, XOM
12/15/2014 12:59:02 PM - BNK Invest


Superbug Antibiotic Resistance: A Solution May Be Closer
12/15/2014 11:49:00 AM - Seeking Alpha


The New Baupost Biotech Picks
12/15/2014 9:53:00 AM - Seeking Alpha


Merger Arbitrage Mondays - December 15, 2014
12/15/2014 9:41:00 AM - Seeking Alpha